The South Dakota Department of Health says it has contacted 13 health care facilities in the state after they were identified as receiving drugs from a Massachusetts firm linked to a multistate outbreak of fungal infections, including meningitis.

Department officials say the clinics were identified this week based on information provided by the FDA and the New England Compounding Center (NECC), which produced the drugs.
South Dakota has reported no cases in this outbreak, but it's not known yet how many patients in South Dakota received the NECC products.

Earlier this month the FDA recalled the steroid injections implicated in the outbreak and this week recalled additional products as a precautionary measure. No South Dakota facilities were identified as receiving the NECC drugs in the initial recall.

State officials say the South Dakota facilities known to have received recalled products from NECC are;
Brookings Ambulatory Surgery Center LLP, Brookings
Bruening Eye Specialists, Dakota Dunes
Siouxland Surgery Center, Dakota Dunes
Anderson Orthopedics, Rapid City
Black Hills Plastic Surgery, Rapid City
Black Hills Regional Eye Institute, Rapid City
Black Hills Surgical Hospital, Rapid City
Rapid City Medical Center, Rapid City
Rapid City Regional Hospital, Rapid City
Sanford Clinic for Ophthalmology and Optometry, Sioux Falls
Dakota Dermatology, Sioux Falls
Lazaderm Skincare Centre, Sioux Falls
Innovative Procedural Center, Watertown

The DoH says the signs and symptoms of meningitis include fever, headache, stiff neck, nausea and vomiting, sensitivity to light and altered mental status.